✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Antengene Corp Ltd

Common Name
Antengene
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
129
Ticker
6996
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Antengene Corporation Limited is a biopharmaceutical company that focuses on discovering, developing, and commercializing innovative oncology medicines. The company's primary function is to provide th...

Antengene's GHG Emissions Data Preview

In 2023, Antengene completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Antengene has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)20232022
Total Scope 1
45.22a
551.32a
Total Scope 2
Unspecified Calculation Method
1,124.76a
1,061.94a
Total Scope 3
N/AN/A
Total Scope 1 Revenue Intensity (tCO2e/$M)
4.775a
23.9729a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=6996&reporting_period=2023"

Verified Sources Behind Antengene’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Antengene's Annual Report 2023

Insights into Antengene's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Antengene amounted to 1,169.98 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Antengene decreased by 27.48%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Antengene's Scope 1 Emissions Over Time

202220230150300450600tCO2e-92%
  • Total Scope 1
  • Year-over-Year Change

What are Antengene's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Antengene were 45.22 metric tons of CO₂ equivalent (tCO₂e).a

Compared to the previous year (2022), Antengene's Scope 1 emissions decreased by 91.8%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are Antengene's Scope 2 emissions?

In 2023, Antengene reported Scope 2 greenhouse gas (GHG) emissions of 1,124.76 tCO₂e without specifying the calculation method.a

Has Antengene reduced its Scope 2 emissions over time?

Compared to the previous year (2022), Antengene's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Antengene's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does Antengene use for Scope 2 reporting?

In 2023, Antengene reported its Scope 2 emissions using an unspecified methodology.a

Antengene's Scope 2 Emissions Over Time

2022202303006009001.2 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Antengene’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Antengene reported Scope 1 greenhouse gas (GHG) emissions of 45.22 tCO₂e and total revenues of USD 9 millions. This translates into an emissions intensity of 4.78 tCO₂e per millions USD.a

Antengene's Scope 1 Emissions Intensity Compared to Peers

0.5102005,000100,000Scope 1 Emissions (tCO2e)2201001,00010,000Revenues (Millions of USD)VIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 342Scope 1 Intensity: 4.11 tCO2e/$MAurisco PharmaceuticalYear: 2024Scope 1: 2,731 tCO2eRevenue: $M 202Scope 1 Intensity: 13.51 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 31Scope 1 Intensity: 128.95 tCO2e/$MAscletis PharmaYear: 2023Scope 1: 422 tCO2eRevenue: $M 8Scope 1 Intensity: 52.94 tCO2e/$MEverest MedicinesYear: 2024Scope 1: 1 tCO2eRevenue: $M 96Scope 1 Intensity: 0.01 tCO2e/$MZai LabYear: 2023Scope 1: 15 tCO2eRevenue: $M 267Scope 1 Intensity: 0.06 tCO2e/$MAscentage PharmaYear: 2023Scope 1: 2,081 tCO2eRevenue: $M 31Scope 1 Intensity: 66.63 tCO2e/$MGenscript BiotechYear: 2024Scope 1: 39,377 tCO2eRevenue: $M 594Scope 1 Intensity: 66.24 tCO2e/$MZhifeiYear: 2024Scope 1: 13,576 tCO2eRevenue: $M 3,572Scope 1 Intensity: 3.80 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 759Scope 1 Intensity: 9.10 tCO2e/$MShanghai Junshi BiosciencesYear: 2024Scope 1: 5,308 tCO2eRevenue: $M 267Scope 1 Intensity: 19.88 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2024Scope 1: 31,787 tCO2eRevenue: $M 795Scope 1 Intensity: 39.96 tCO2e/$MInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,248Scope 1 Intensity: 10.66 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 217Scope 1 Intensity: 29.23 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 291Scope 1 Intensity: 22.02 tCO2e/$MWuXi Biologics (Cayman)Year: 2024Scope 1: 38,346 tCO2eRevenue: $M 2,559Scope 1 Intensity: 14.99 tCO2e/$MInnovent BiologicsYear: 2024Scope 1: 48 tCO2eRevenue: $M 1,291Scope 1 Intensity: 0.04 tCO2e/$MEdding Genor Group HoldingsYear: 2022Scope 1: 18 tCO2eRevenue: $M 2Scope 1 Intensity: 7.18 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 9Scope 1 Intensity: 3.80 tCO2e/$MCARsgen Therapeutics HoldingsYear: 2021Scope 1: 117 tCO2eRevenue: $M 4Scope 1 Intensity: 28.91 tCO2e/$MAntengeneYear: 2023Scope 1: 45 tCO2eRevenue: $M 9Scope 1 Intensity: 4.78 tCO2e/$M

How does Antengene's GHG emissions intensity compare to its peers?

In 2023, Antengene reported a Scope 1 emissions intensity of 4.78 tCO₂e per millions USD. Compared to the peer group median of 13.51, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Antengene rank on GHG emissions intensity within its industry?

In 2023, Antengene ranked 9 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Antengene is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Want Full Access to Antengene's GHG Emissions Dataset?
Start 30-Day Free Trial